| abstract |
The invention provides, among other things, methods for treating an ischemic tissue in a subject in need thereof. The invention further provides methods for increasing the blood flow to an ischemic tissue in a subject in need thereof, such as to ischemic myocardium. The invention provides uses of cells, including but not limited to CD133+ cells, for the manufacture of medicaments for treating ischemic. The invention further provides cell-based formulations and related kits. |